SEARCH

SEARCH BY CITATION

References

  • Akoz, A.G., Yildirim, N., Engin, H., Dagdas, S., Ozet, G., Tekin, I.O. & Ceran, F. (2007) An unusual case of spontaneous acute tumor lysis syndrome associated with acute lymphoblastic leukemia: a case report and review of the literature. Acta Oncologica, 46, 11901192.
  • Annemans, L., Moeremans, K., Lamotte, M., Garcia Conde, J., Van Den Berg, H., Myint, H., Pieters, R. & Uyttebroeck, A. (2003) Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin’s lymphoma in four European countries. Leukaemia & Lymphoma, 44, 7783.
  • Arseneau, J.C., Canellos, G.P., Banks, P.M., Berard, C.W., Gralnick, H.R. & DeVita, Jr, V.T. (1975) American Burkitt’s lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. American Journal of Medicine, 58, 314321.
  • Baeksgaard, L. & Sorensen, J.B. (2003) Acute tumor lysis syndrome in solid tumors--a case report and review of the literature. Cancer Chemotherapy and Pharmacology, 51, 187192.
  • Bertrand, Y., Mechinaud, F., Brethon, B., Mialou, V., Auvrignon, A., Nelken, B., Notz-Carrere, A., Plantaz, D., Patte, C., Urbieta, M., Baruchel, A. & Leverger, G. (2008) SFCE (Societe Francaise de Lutte contre les Cancers et Leucemies de l’Enfant et de l’Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey. Journal of Pediatric Hematology/oncology, 30, 267271.
  • Bosly, A., Sonet, A., Pinkerton, C.R., McCowage, G., Bron, D., Sanz, M.A. & Van den Berg, H. (2003) Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study. Cancer, 98, 10481054.
  • Cairo, M.S. & Bishop, M. (2004) Tumour lysis syndrome: new therapeutic strategies and classification. British Journal of Haematology, 127, 311.
  • Calvo-Villas, J.M., Urcuyo, B.M., Umpierrez, A.M. & Sicilia, F. (2008) Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase. Onkologie, 31, 197199.
  • Candrilli, S., Bell, T., Irish, W., Morris, E., Goldman, S. & Cairo, M.S. (2008) A comparison of inpatient length of stay and costs among patients with hematologic malignancies (excluding hodgkin disease) associated with and without acute renal failure. Clinical Lymphoma & Myeloma, 8, 4451.
  • Chen, R.L. & Chuang, S.S. (2009) Transient spontaneous remission after tumor lysis syndrome triggered by a severe pulmonary infection in an adolescent boy with acute lymphoblastic leukemia. Journal of Pediatric Hematology/oncology, 31, 7679.
  • Cheson, B.D., Frame, J.N., Vena, D., Quashu, N. & Sorensen, J.M. (1998) Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia. Journal of Clinical Oncology, 16, 23132320.
  • Choi, K.A., Lee, J.E., Kim, Y.G., Kim, D.J., Kim, K., Ko, Y.H., Oh, H.Y., Kim, W.S. & Huh, W. (2009) Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome. Annals of Hematology, 88, 639645.
  • Coiffier, B., Altman, A., Pui, C.H., Younes, A. & Cairo, M.S. (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. Journal of Clinical Oncology, 26, 27672778.
  • DeConti, R.C. & Calabresi, P. (1966) Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease. New England Journal of Medicine, 274, 481486.
  • Dillman, R.O. & Hendrix, C.S. (2003) Unique aspects of supportive care using monoclonal antibodies in cancer treatment. Supportive Cancer Therapy, 1, 3848.
  • Drakos, P., Bar-Ziv, J. & Catane, R. (1994) Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature. American Journal of Clinical Oncology, 17, 502505.
  • Francescone, S.A., Murphy, B., Fallon, J.T., Hammond, K. & Pinney, S. (2009) Tumor lysis syndrome occurring after the administration of rituximab for posttransplant lymphoproliferative disorder. Transplantation Proceedings, 41, 19461948.
  • Hande, K.R. & Garrow, G.C. (1993) Acute tumor lysis syndrome in patients with high-grade non-Hodgkin’s lymphoma. American Journal of Medicine, 94, 133139.
  • Harbour, R. & Miller, J. (2001) A new system for grading recommendations in evidence based guidelines. BMJ, 323, 334336.
  • Hochberg, J. & Cairo, M.S. (2008) Tumor lysis syndrome: current perspective. Haematologica, 93, 913.
  • Hsu, H.H., Chan, Y.L. & Huang, C.C. (2004) Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: clinical features and therapeutic approach. Journal of Nephrology, 17, 5056.
  • Hummel, M., Buchheidt, D., Reiter, S., Bergmann, J., Adam, K. & Hehlmann, R. (2005) Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase. European Journal of Haematology, 75, 518521.
  • Hussain, K., Mazza, J.J. & Clouse, L.H. (2003) Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature. American Journal of Hematology, 72, 212215.
  • Kalemkerian, G.P., Darwish, B. & Varterasian, M.L. (1997) Tumor lysis syndrome in small cell carcinoma and other solid tumors. American Journal of Medicine, 103, 363367.
  • Konuma, T., Ooi, J., Takahashi, S., Tomonari, A., Tsukada, N., Kato, S., Sato, A., Monma, F., Uchimaru, K. & Tojo, A. (2008) Fatal acute tumor lysis syndrome following intrathecal chemotherapy for acute lymphoblastic leukemia with meningeal involvement. Internal Medicine, 47, 19871988.
  • Kunkel, L., Wong, A., Maneatis, T., Nickas, J., Brown, T., Grillo-Lopez, A., Benyunes, M., Grobman, B. & Dillman, R.O. (2000) Optimizing the use of rituximab for treatment of B-cell non-Hodgkin’s lymphoma: a benefit-risk update. Seminars in Oncology, 27, 5361.
  • Landgrebe, A.R., Nyhan, W.L. & Coleman, M. (1975) Urinary-tract stones resulting from the excretion of oxypurinol. New England Journal of Medicine, 292, 626627.
  • Levine, A.M. (2002) Challenges in the management of Burkitt’s lymphoma. Clinical Lymphoma, 3(Suppl. 1), S19S25.
  • Lin, T.S. (2008) Novel agents in chronic lymphocytic leukemia: efficacy and tolerability of new therapies. Clinical Lymphoma & Myeloma, 8(Suppl. 4), S137S143.
  • Lin, C.J., Chen, H.H., Hsieh, R.K., Chen, Y.C. & Wu, C.J. (2009) Acute tumor lysis syndrome in a hemodialysis patient with diffuse large B cell lymphoma. Medical Oncology, 26, 9395.
  • Locatelli, F. & Rossi, F. (2005) Incidence and pathogenesis of tumor lysis syndrome. Contributions to Nephrology, 147, 6168.
  • Michallet, A.S., Tartas, S. & Coiffier, B. (2005) Optimizing management of tumor lysis syndrome in adults with hematologic malignancies. Supportive Cancer Therapy, 2, 159166.
  • Montesinos, P., Lorenzo, I., Martin, G., Sanz, J., Perez-Sirvent, M.L., Martinez, D., Orti, G., Algarra, L., Martinez, J., Moscardo, F., De La Rubia, J., Jarque, I., Sanz, G. & Sanz, M.A. (2008) Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Haematologica, 93, 6774.
  • Navolanic, P.M., Pui, C.H., Larson, R.A., Bishop, M.R., Pearce, T.E., Cairo, M.S., Goldman, S.C., Jeha, S.C., Shanholtz, C.B., Leonard, J.P. & McCubrey, J.A. (2003) Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002. Leukemia, 17, 499514.
  • Phelps, M.A., Lin, T.S., Johnson, A.J., Hurh, E., Rozewski, D.M., Farley, K.L., Wu, D., Blum, K.A., Fischer, B., Mitchell, S.M., Moran, M.E., Brooker-McEldowney, M., Heerema, N.A., Jarjoura, D., Schaaf, L.J., Byrd, J.C., Grever, M.R. & Dalton, J.T. (2009) Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia. Blood, 113, 26372645.
  • Seidemann, K., Meyer, U., Jansen, P., Yakisan, E., Rieske, K., Fuhrer, M., Kremens, B., Schrappe, M. & Reiter, A. (1998) Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin’s lymphoma and B-ALL. Observations from the BFM-trials. Klinische Padiatrie, 210, 279284.
  • Stapleton, F.B., Strother, D.R., Roy, III, S., Wyatt, R.J., McKay, C.P. & Murphy, S.B. (1988) Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma. Pediatrics, 82, 863869.
  • Tosi, P., Barosi, G., Lazzaro, C., Liso, V., Marchetti, M., Morra, E., Pession, A., Rosti, G., Santoro, A., Zinzani, P.L. & Tura, S. (2008) Consensus conference on the management of tumor lysis syndrome. Haematologica, 93, 18771885.
  • Truong, T.H., Beyene, J., Hitzler, J., Abla, O., Maloney, A.M., Weitzman, S. & Sung, L. (2007) Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome. Cancer, 110, 18321839.
  • Tsokos, G.C., Balow, J.E., Spiegel, R.J. & Magrath, I.T. (1981) Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. Medicine (Baltimore), 60, 218229.
  • Vaisban, E., Zaina, A., Braester, A., Manaster, J. & Horn, Y. (2001) Acute tumor lysis syndrome induced by high-dose corticosteroids in a patient with chronic lymphatic leukemia. Annals of Hematology, 80, 314315.
  • Vaisban, E., Braester, A., Mosenzon, O., Kolin, M. & Horn, Y. (2003) Spontaneous tumor lysis syndrome in solid tumors: really a rare condition? American Journal of the Medical Sciences, 325, 3840.
  • Wossmann, W., Schrappe, M., Meyer, U., Zimmermann, M. & Reiter, A. (2003) Incidence of tumor lysis syndrome in children with advanced stage Burkitt’s lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase. Annals of Hematology, 82, 160165.
  • Yim, B.T., Sims-McCallum, R.P. & Chong, P.H. (2003) Rasburicase for the treatment and prevention of hyperuricemia. Annals of Pharmacotherapy, 37, 10471054.